Clinical Trial Update: Modulation of Adjuvant 5-FU by Folinic Acid and Interferon-alpha in Colon Cancer [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating modulation of adjuvant 5-FU by folinic acid and interferon-alpha in colorectal cancer (colon and rectal cancer) has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colon Cancer
• Colorectal Cancer
• Rectal Cancer

Drugs mentioned

• 5-Fluorouracil (5-FU)
• Folinic acid (folinic acid)
• Interferon-alpha (interferon alpha)

Snippet

Sponsor: University of Ulm | Conditions: Rectal Cancer | Phase 3 | Status: COMPLETED